Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study-Reference-Cited by-同舟云学术

Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study

Published:2009-03 Issue:3 Volume:112 Page:563-567
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hensley Martee L.,Ishill Nicole,Soslow Robert,Larkin Joseph,Abu-Rustum Nadeem,Sabbatini Paul,Konner Jason,Tew William,Spriggs David,Aghajanian Carol A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference25 articles.

1. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study;Major;Cancer,1993

2. The prognostic significance of stage, tumor size, cellular atypia, and DNA ploidy in uterine leiomyosarcoma;Nordal;Acta Oncol.,1995

3. Endometrial stromal sarcoma: analysis of treatment failures and survival;Gadducci;Gynecol. Oncol.,1996

4. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990–1999) at the Massachusetts General Hospital;Dinh;Gynecol. Oncol.,2004

5. Leiomyosarcoma of the uterus;Dinh;Am. J. Obstet. gynecol.,1982

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine Leiomyosarcoma in a 22-Year-Old Young Woman: A Case Report;Cureus;2024-06-10

2. Current Treatment Options: Uterine Sarcoma;Current Treatment Options in Oncology;2024-05-31

3. UK guidelines for the management of soft tissue sarcomas;British Journal of Cancer;2024-05-11

4. Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma;Frontiers in Oncology;2023-11-28

5. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years’ clinical experience from a tertiary care center in Pakistan;BMC Cancer;2023-06-05